| NCT06439888 | Gustave Roussy, Cancer Campus, Grand Paris | Oligometastatic Disease|Solid Tumor, Adult | 2024-07-11 | PHASE1|PHASE2 |
| NCT04353180 | Kafrelsheikh University|The First Hospital of Jilin University|2-Montefiore Health System and Albert Einstein College of Medicine, Newyork, United States of America (U.S.A). | COVID19 | 2021-08 | PHASE3 |
| NCT02641782 | University of Cologne | Neuroblastoma | 2015-11 | PHASE2 |
| NCT00000621 | National Heart, Lung, and Blood Institute (NHLBI) | Emphysema|Lung Diseases|Lung Diseases, Obstructive|Chronic Obstructive Pulmonary Disease | 1999-09 | PHASE2 |
| NCT05175508 | The First Affiliated Hospital of Soochow University | AML|MDS|Old Age; Debility|Hematologic Cancer | 2021-05-01 | PHASE2|PHASE3 |
| NCT02899169 | First Affiliated Hospital Xi´an Jiaotong University|Tang-Du Hospital | Acute Promyelocytic Leukemia | 2016-09-01 | PHASE3 |
| NCT06646666 | Ruijin Hospital | B-cell Non Hodgkin Lymphoma | 2024-12-01 | PHASE2 |
| NCT06731140 | Fudan University | HER2 Negative Breast Cancer | 2025-02-12 | PHASE2 |
| NCT00892190 | University of Pittsburgh | Acute Myelogenous Leukemia|Myelodysplastic Syndrome | 2011-04 | PHASE1 |
| NCT00617409 | H. Lee Moffitt Cancer Center and Research Institute | Small Cell Lung Cancer | 2007-10-02 | PHASE2 |
| NCT01276730 | University of Louisville|James Graham Brown Cancer Center | Cervical Cancer | 2007-10 | PHASE2 |
| NCT02751255 | Amsterdam UMC, location VUmc|Erasmus Medical Center|UMC Utrecht|University of Turin, Italy|Vejle Hospital | Multiple Myeloma | 2016-07-06 | PHASE1|PHASE2 |
| NCT04382950 | Kafrelsheikh University | COVID | 2021-07 | PHASE1 |
| NCT03259516 | St. Petersburg State Pavlov Medical University | Myelodysplastic Syndromes | 2017-05-25 | PHASE1|PHASE2 |
| NCT00151242 | University of Ulm | Acute Myeloid Leukemia | 2004-07 | PHASE2|PHASE3 |
| NCT07187505 | Anhui Medical University|The First Affiliated Hospital of Anhui Medical University | Acute Promyelocytic Leukemia (APL) | 2025-07-01 | NA |
| NCT05482451 | China Medical University Hospital | Effect of Drug | 2021-03-01 | EARLY_PHASE1 |
| NCT03370367 | Eastern Cooperative Oncology Group | Stage I-II Head and Neck Cancer | 1989-05-15 | PHASE3 |
| NCT00601796 | H. Lee Moffitt Cancer Center and Research Institute|National Cancer Institute (NCI)|National Institutes of Health (NIH) | Lung Cancer | 2006-10 | PHASE2 |
| NCT03200847 | University of Colorado, Denver|Merck Sharp & Dohme LLC | Stage IV Melanoma|Stage III Melanoma|Advanced Melanoma | 2017-10-31 | PHASE1|PHASE2 |
| NCT02497833 | Sun Yat-sen University | Hypercholesterolemia | 2014-11 | EARLY_PHASE1 |
| NCT00326170 | M.D. Anderson Cancer Center|Celgene Corporation | Myelodysplastic Syndrome|Acute Myelogenous Leukemia | 2005-07 | PHASE2 |
| NCT00413166 | M.D. Anderson Cancer Center | Acute Promyelocytic Leukemia | 2006-12 | PHASE2 |
| NCT06158412 | The First Affiliated Hospital of Xiamen University | Multiple Myeloma in Relapse|Multiple Myeloma, Refractory | 2023-11-22 | PHASE2 |
| NCT04623385 | Kafrelsheikh University | Covid19 | 2020-11 | PHASE4 |
| NCT03572387 | Icahn School of Medicine at Mount Sinai | Prostatic Neoplasms|Prostate Neoplasms|Prostate Cancer | 2018-08-20 | PHASE2 |
| NCT05281965 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Autism|Treatment Adherence|Retinoic Acid|Dup15Q Syndrome | 2022-04-01 | EARLY_PHASE1 |
| NCT01064557 | Gruppo Italiano Malattie EMatologiche dell´Adulto | Leukemia | 1993-10 | NA |
| NCT07296445 | SDK Therapeutics, Inc. | Acute Promyelocytic Leukemia (APL)|Acute Promyelocytic Leukaemia|Acute Promyelocytic Leukemia With PML-RARA|Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA|APL|Acute Promyelocytic Leukemia|Leukaemia|Leukemia Acute Promyelocytic Leukemia (APL)|Leukemia, Acute | 2026-01 | PHASE3 |
| NCT02061384 | University of Washington | Male Infertility|Klinefelter´s Syndrome|Y-chromosome Microdeletions | 2014-08 | PHASE2 |
| NCT01064570 | Gruppo Italiano Malattie EMatologiche dell´Adulto | Acute Promyelocytic Leukemia | 2000-05 | PHASE2 |
| NCT02712905 | Incyte Corporation | Solid Tumors and Hematologic Malignancy | 2016-05-05 | PHASE1|PHASE2 |
| NCT00533169 | M.D. Anderson Cancer Center|AstraZeneca | Neuroblastoma | 2007-09 | PHASE1 |
| NCT00135135 | St. Jude Children´s Research Hospital|AstraZeneca|National Institutes of Health (NIH) | Neuroblastoma | 2005-08 | PHASE2 |
| NCT05077813 | Kafrelsheikh University|Ministry of Health, Saudi Arabia | Tuberculosis | 2021-12 | PHASE2 |
| NCT05345002 | Stephen Bagley, MD, MSCE|Incyte Corporation|Abramson Cancer Center at Penn Medicine | Glioma|IDH Mutation|Astrocytoma|Oligodendroglioma | 2022-11-16 | PHASE2 |
| NCT06020833 | Peking Union Medical College Hospital | Myelodysplastic Syndromes | 2023-08 | PHASE1|PHASE2 |
| NCT03291080 | Nova Laboratories Limited | Neuroblastoma | 2018-04-17 | PHASE1|PHASE2 |
| NCT04730895 | Kafrelsheikh University | Covid19 Vaccine | 2021-07 | PHASE1|PHASE2 |
| NCT00136461 | Dana-Farber Cancer Institute|Brigham and Women´s Hospital | Acute Myelogenous Leukemia|Myelodysplastic Syndrome | 1997-05 | PHASE2 |
| NCT03323801 | University of Washington|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Male Infertility, Azoospermia | 2017-07-25 | PHASE2 |
| NCT04577378 | Kafrelsheikh University | Covid19 | 2020-10-20 | PHASE2 |
| NCT04568096 | Kafrelsheikh University | the Lung Complication of COVID-19 | 2020-11 | PHASE2 |
| NCT05016349 | Mahmoud Ramadan mohamed Elkazzaz|Ministry of Health, Saudi Arabia | Breast Cancer Female | 2021-08 | PHASE3 |
| NCT01161550 | Washington University School of Medicine | Leukemia, Myeloid, Acute | 2010-11 | PHASE1 |
| NCT01275274 | University of North Carolina, Chapel Hill|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 2012-01 | PHASE2 |
| NCT00175812 | University of Bergen | Acute Myelogenous Leukemia | 2004-11 | PHASE1|PHASE2 |
| NCT03031249 | Institute of Hematology & Blood Diseases Hospital, China | AML | 2017-02-08 | PHASE1|PHASE2 |
| NCT02717884 | Michael Luebbert|University Hospital Freiburg | Acute Myeloid Leukemia|Myelodysplastic Syndrome | 2015-05 | PHASE1|PHASE2 |
| NCT07015931 | Indonesia University | Acne Vulgaris | 2024-11-30 | PHASE1|PHASE2 |
| NCT04578236 | Kafrelsheikh University | Covid19 | 2020-11 | PHASE2 |
| NCT05999812 | University of Texas Southwestern Medical Center|Genentech, Inc. | Colorectal Cancer | 2023-12-19 | PHASE2 |
| NCT05002530 | Kafrelsheikh University|Ministry of Health, Saudi Arabia|The First Hospital of Jilin University|Montefiore Health System and Albert Einstein College of Medicine, Newyork, United States of America (USA) | Post COVID-19 Anosmia (Loss of Smell) | 2021-11 | PHASE4 |
| NCT00002586 | University of Colorado, Denver | Drug Toxicity|Lung Cancer | 1993-01 | PHASE2 |
| NCT04700176 | Hackensack Meridian Health|Janssen, LP | Multiple Myeloma | 2022-05-02 | PHASE2 |
| NCT04113863 | Mario Negri Institute for Pharmacological Research | Breast Neoplasm Female | 2019-06-18 | PHASE2 |
| NCT03359174 | Yale University | Cholangitis, Sclerosing | 2018-05-29 | PHASE2 |
| NCT00151255 | University of Ulm | Acute Myeloid Leukemia | 2004-06 | PHASE3 |
| NCT00339196 | Assistance Publique - H?pitaux de Paris | Acute Myelogenous Leukaemia (AML)|Myelodysplastic Syndrome (MDS) | 2006-07 | PHASE2 |
| NCT01048086 | University of Iowa|Molecular Insight Pharmaceuticals, Inc. | Neuroblastoma|Neuroendocrine Tumor | 2009-06 | PHASE2 |
| NCT03304288 | Peking University People´s Hospital|Beijing Hospital|Navy General Hospital, Beijing|Beijing Tongren Hospital | Immune Thrombocytopenia | 2017-10-11 | PHASE2 |
| NCT01985477 | M.D. Anderson Cancer Center|Celgene Corporation | Myeloma | 2013-12 | PHASE1 |
| NCT04793919 | Associazione Italiana Ematologia Oncologia Pediatrica | Acute Promyelocytic Leukemia | 2019-10-09 | PHASE2 |
| NCT00001509 | National Cancer Institute (NCI) | Nephroblastoma|Neuroblastoma | 1996-07 | PHASE2 |
| NCT00995332 | University of Bergen | Acute Myelogenous Leukemia | 2009-09 | PHASE1|PHASE2 |
| NCT00482833 | Gruppo Italiano Malattie EMatologiche dell´Adulto|Study Alliance Leukemia (SAL) Group | Leukemia | 2007-08 | PHASE3 |
| NCT01456468 | Yale University|Mayo Clinic | Cholangitis, Sclerosing | 2011-10 | PHASE1 |
| NCT07278908 | Institute of Hematology & Blood Diseases Hospital, China | ITP - Immune Thrombocytopenia | 2025-12 | PHASE2|PHASE3 |
| NCT04477382 | Ecarf Institute GmbH|Bencard Allergie GmbH | Dust Mite Allergy|Allergic Rhinitis | 2020-01-06 | |
| NCT06536413 | The Methodist Hospital Research Institute|Cancer Prevention Research Institute of Texas | Multiple Myeloma | 2024-07-29 | PHASE1|PHASE2 |
| NCT01237808 | University of Ulm|German Federal Ministry of Education and Research | Acute Myeloid Leukemia (AML) | 2011-03 | PHASE3 |
| NCT04417348 | Universidad Autonoma de San Luis Potosí|Hospital Central "Dr. Ignacio Morones Prieto" | Melasma | 2019-01-31 | NA |
| NCT05497310 | Hospital Universitario Dr. Jose E. Gonzalez | Promyelocytic Leukemia | 2022-07-01 | PHASE1|PHASE2 |
| NCT03392623 | Universidad Autonoma de San Luis Potosí | Melasma | 2015-01-01 | EARLY_PHASE1 |
| NCT04396067 | Kafrelsheikh University|New Damietta University Hospital | COVID-19 | 2020-10 | PHASE2 |
| NCT01667263 | Peking University People´s Hospital|Beijing Municipal Science & Technology Commission|Beijing Hospital|Qilu Hospital of Shandong University|Navy General Hospital, Beijing|Beijing Tongren Hospital | Autoimmune Thrombocytopenia | 2012-06-01 | PHASE2 |
| NCT05438875 | Peking University People´s Hospital|Beijing Friendship Hospital|Beijing Tongren Hospital|Beijing Hospital|Navy General Hospital, Beijing | Purpura, Thrombocytopenic, Idiopathic | 2022-10-12 | PHASE3 |
| NCT05297123 | First Affiliated Hospital Xi´an Jiaotong University | Acute Myeloid Leukemia | 2019-02-03 | PHASE1 |
| NCT03491267 | Johns Hopkins University|National Institute Of Arthritis & Musculoskeletal & Skin Diseases | Central Centrifugal Cicatricial Alopecia (CCCA) | 2018-01-01 | EARLY_PHASE1 |
| NCT04618328 | Peking University People´s Hospital|Qilu Hospital of Shandong University|Beijing Hospital|Navy General Hospital, Beijing | Immune Thrombocytopenia | 2020-11 | PHASE2 |
| NCT00001438 | National Cancer Institute (NCI) | HIV Infections|Immunologic Deficiency Syndromes|Lymphoproliferative Disorders | 1995-06 | PHASE2 |
| NCT00867672 | University Hospital Freiburg | Acute Myeloid Leukemia | 2011-08 | PHASE2 |
| NCT04324411 | Peking Union Medical College Hospital | Autoimmune Anemia | 2020-04-01 | PHASE2|PHASE3 |
| NCT04305054 | Merck Sharp & Dohme LLC | Melanoma | 2020-07-01 | PHASE1|PHASE2 |
| NCT02200978 | South China Children´s Leukemia Group | Childhood Acute Promyelocytic Leukemia | 2011-09 | PHASE4 |
| NCT03624270 | The University of Hong Kong | Acute Promyelocytic Leukemia | 2018-08-15 | PHASE2 |
| NCT07503730 | First Affiliated Hospital Xi´an Jiaotong University | APL | 2025-06-01 | PHASE3 |
| NCT02020161 | PETHEMA Foundation | APL | 2012-06 | PHASE4 |
| NCT05654194 | The First Affiliated Hospital of Soochow University | Acute Myeloid Leukemia | 2022-10-31 | PHASE3 |
| NCT02401295 | University of Iowa | Relapsed Multiple Myeloma | 2015-05 | PHASE1 |
| NCT04241276 | Queen Mary University of London|Medical Research Council|Celgene | Pancreatic Cancer | 2020-04-30 | PHASE2 |
| NCT00599937 | Groupe d´etude et de travail sur les leucemies aigues promyelocytaires|DRC lille, France | Leukemia, Promyelocytic, Acute | 1993-01 | PHASE3 |
| NCT07348107 | Daniel Breadner|BeiGene (Canada) ULC|SDK Therapeutics, Inc. | Advanced Pancreatic Ductal Adenocarcinoma | 2026-02-15 | PHASE1 |
| NCT06728631 | Shanghai Ninth People´s Hospital Affiliated to Shanghai Jiao Tong University | Oral Cavity Cancer|Premalignant Lesion | 2020-06-30 | PHASE2 |
| NCT04305041 | Merck Sharp & Dohme LLC | Melanoma | 2020-06-26 | PHASE1|PHASE2 |
| NCT04282668 | Taiho Oncology, Inc. | Acute Myeloid Leukemia | 2020-03-15 | PHASE1 |
| NCT01048645 | National Institute of Cancerología|Instituto Nacional de Enfermedades Respiratorias | Non-Small-Cell Lung Carcinoma | 2007-09 | PHASE2 |
| NCT06484920 | Rita Assi | Relapsed Hodgkin Lymphoma|Refractory Hodgkin Lymphoma|Relapsed Non-Hodgkin Lymphoma|Refractory Non-Hodgkin Lymphoma|B-cell Lymphoma | 2024-11-18 | PHASE2 |
| NCT01226303 | Associazione Italiana Ematologia Oncologia Pediatrica | Acute Promyelocytic Leukemia | 2009-01 | PHASE3 |
| NCT02177812 | GlaxoSmithKline | Leukaemia, Myelocytic, Acute | 2014-08-27 | PHASE1 |
| NCT00962767 | Wyeth is now a wholly owned subsidiary of Pfizer | Leukemia, Myelocytic, Acute | 2002-05 | PHASE3 |
| NCT01882127 | Shandong University | Purpura|Idiopathic Thrombocytopenic Purpura | 2013-02 | PHASE3 |
| NCT00100906 | H. Lee Moffitt Cancer Center and Research Institute|National Cancer Institute (NCI)|National Institutes of Health (NIH)|Chiron Corporation | Kidney Cancer | 2004-08 | PHASE2 |
| NCT00400556 | Peter MacCallum Cancer Centre, Australia|The Leukemia and Lymphoma Society | Multiple Myeloma|Cutaneous Lymphoma | 2005-03 | PHASE1 |
| NCT00504764 | PETHEMA Foundation | Acute Promyelocytic Leukemia | 2007-07 | PHASE4 |
| NCT01067274 | Acute Leukemia French Association|Assistance Publique - H?pitaux de Paris | Acute Myeloid Leukemia | 2010-04 | PHASE3 |
| NCT06371274 | First Affiliated Hospital of Zhejiang University|Shanghai Longfine Biotechnology Co., Ltd.|TopAlliance | Triple-negative Breast Cancer | 2024-10-10 | NA |
| NCT00378365 | Assistance Publique - H?pitaux de Paris | Leukemia, Promyelocytic, Acute | 2006-10 | PHASE3 |
| NCT03307148 | Barts & The London NHS Trust|Medical Research Council|Celgene Corporation|Cancer Research UK Cambridge Institute|King´s College London|Royal Free Hospital NHS Foundation Trust|Imperial College Healthcare NHS Trust|Institute of Cancer Research, United Kingdom|Cambridge University Hospitals NHS Foundation Trust | Pancreatic Adenocarcinoma | 2016-01-15 | PHASE1 |
| NCT04217148 | Peking University People´s Hospital|Beijing Hospital|Navy General Hospital, Beijing|Beijing Aerospace General Hospital|Qilu Hospital of Shandong University|Beijing Tongren Hospital | Immune Thrombocytopenia | 2020-01-01 | PHASE2 |
| NCT04303169 | Merck Sharp & Dohme LLC | Melanoma | 2020-06-26 | PHASE1|PHASE2 |
| NCT00439673 | Gruppo Italiano Malattie EMatologiche dell´Adulto | Myelodysplastic Syndromes | 2007-05 | PHASE2 |
| NCT00408278 | PETHEMA Foundation | Acute Promyelocytic Leukemia | 2005-07 | PHASE4 |
| NCT07504458 | Quetzal Therapeutics | Acute Promyelocytic Leukemia (APL)|Acute Promyelocytic Leukaemia|Acute Promyelocytic Leukemia With PML-RARA|Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA|Acute Promyelocytic Leukemia | 2026-04 | PHASE3 |
| NCT02942758 | University Hospital Regensburg|Anticancer Fund, Belgium|Celgene | Acute Myeloid Leukemia | 2017-04-10 | PHASE2 |
| NCT07079696 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Dup15q Syndrome|Autism Spectrum Disorder|Therapy|All-trans Retinoic Acid | 2025-09-01 | PHASE2 |
| NCT01041833 | National Institute of Cancerología | Non Small Cell Lung Cancer | 2010-01 | PHASE3 |